Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database
Bum Sik Tae, Byung Jo Jeon, Seung Hun Shin, Hoon Choi, Jae Hyun Bae, Jae Young Park
Cancer Res Treat. 2019;51(2):593-602.   Published online 2018 Jul 18     DOI:
Citations to this article as recorded by Crossref logo
Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis
Haiying Cui, Yao Wang, Fei Li, Guangyu He, Zongmiao Jiang, Xiaokun Gang, Guixia Wang
Prostate Cancer and Prostatic Diseases.2021; 24(1): 15.     CrossRef
Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?
Myungsun Shim, Woo Jin Bang, Cheol Young Oh, Yong Seong Lee, Jin Seon Cho
Prostate International.2021;[Epub]     CrossRef
Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor Inhibitors
Alicia K. Morgans, Joseph Renzulli, Kara Olivier, Neal D. Shore
Clinical Genitourinary Cancer.2021;[Epub]     CrossRef
Antiaging Therapies, Cognitive Impairment, and Dementia
Devin Wahl, Rozalyn M Anderson, David G Le Couteur, Rafael de Cabo
The Journals of Gerontology: Series A.2020; 75(9): 1643.     CrossRef
A review of prostate cancer treatment impact on the CNS and cognitive function
Charles Ryan, Jeffrey S. Wefel, Alicia K. Morgans
Prostate Cancer and Prostatic Diseases.2020; 23(2): 207.     CrossRef
Diagnostic accuracy of administrative database for bile duct cancer by ICD-10 code in a tertiary institute in Korea
Young-Jae Hwang, Seon Mee Park, Soomin Ahn, Jongchan Lee, Young Soo Park, Nayoung Kim
Hepatobiliary & Pancreatic Diseases International.2020; 19(6): 575.     CrossRef
WITHDRAWN: The Changes of ADC Value, DCE-MRI Parameters and Their Influence on Neuropsychology in Prostate Cancer Patients after Endocrine Therapy Based on Magnetic Resonance Imaging
Yang Lu, Shang Ge, Yan Liu, Gengji Bai
Neuroscience Letters.2020; : 135221.     CrossRef
Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician
Aisha L. Siebert, Leiszle Lapping-Carr, Alicia K. Morgans
European Urology Focus.2020; 6(6): 1170.     CrossRef
An Updated Review: Androgens and Cognitive Impairment in Older Men
Zhonglin Cai, Hongjun Li
Frontiers in Endocrinology.2020;[Epub]     CrossRef
Risk of dementia and Parkinson’s disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study
Myungsun Shim, Woo Jin Bang, Cheol Young Oh, Yong Seong Lee, Seong Soo Jeon, Hanjong Ahn, Young-Su Ju, Jin Seon Cho, Gianluigi Forloni
PLOS ONE.2020; 15(12): e0244660.     CrossRef
Androgen deprivation therapy for prostate cancer and risk of dementia
David Robinson, Hans Garmo, Mieke Van Hemelrijck, Jan-Erik Damber, Ola Bratt, Lars Holmberg, Lars-Olof Wahlund, Pär Stattin, Jan Adolfsson
BJU International.2019;[Epub]     CrossRef
Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer
Nirmish Singla, Rashed A. Ghandour, Ganesh V. Raj
Expert Opinion on Investigational Drugs.2019; 28(3): 249.     CrossRef
Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis
Omar Saeed, Lori J. Bernstein, Rouhi Fazelzad, Mary Samuels, Lynn A. Burmeister, Lehana Thabane, Shereen Ezzat, David P. Goldstein, Jennifer Jones, Anna M. Sawka
Journal of Cancer Survivorship.2019; 13(2): 231.     CrossRef
Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
Bum Sik Tae, Byeong Jo Jeon, Hoon Choi, Jae Hyun Bae, Jae Young Park
Cancer Medicine.2019; 8(9): 4475.     CrossRef